Canada Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: June 23, 2025 Report Code: GDME0632MDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “Canada Drug Delivery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Canada Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Infusion Systems, Central Venous Catheters and Implantable Ports

The Canada Drug Delivery Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Drug Delivery Devices Market.
• Global corporate-level profiles of key companies operating within the Canada Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Canada Drug Delivery Devices is segmented as follows –

• Infusion Systems

• Central Venous Catheters

• Implantable Ports

Reasons to Buy

The Canada Drug Delivery Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

B. Braun Melsungen AG_x000D_
Becton Dickinson and Co_x000D_
Teleflex Inc_x000D_
Baxter International Inc_x000D_
ICU Medical Inc_x000D_
Edwards Lifesciences Corp_x000D_
Vygon SA

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Drug Delivery Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Drug Delivery Devices Market, Canada 11

3.1 Drug Delivery Devices Market, Canada, Revenue ($m), 2018-2033 11

3.2 Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2023 12

3.3 Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2023 13

3.4 Drug Delivery Devices Market, Canada, Revenue ($m), 2018-2033 14

3.5 Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 16

3.6 Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 17

3.7 Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), 2023 19

4 Central Venous Catheters Market, Canada 21

4.1 Central Venous Catheters Market, Canada, Revenue Mix ($m), 2023 21

4.2 Central Venous Catheters Market, Canada, Segment Contribution (%), 2023 22

4.3 Central Venous Catheters Market, Canada, Revenue ($m), 2018-2033 23

4.4 Central Venous Catheters Market, Canada, Volume (Units), 2018-2033 25

4.5 Central Venous Catheters Market, Canada, Average Price ($) , 2018-2033 27

4.6 Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), 2023 28

4.7 Central Venous Catheters Market, Canada, Company Share by Revenue ($m), 2023 29

5 Implantable Ports Market, Canada 31

5.1 Implantable Ports Market, Canada, Revenue Mix ($m), 2023 31

5.2 Implantable Ports Market, Canada, Segment Contribution (%), 2023 32

5.3 Implantable Ports Market, Canada, Revenue ($m), 2018-2033 33

5.4 Implantable Ports Market, Canada, Volume (Units), 2018-2033 35

5.5 Implantable Ports Market, Canada, Average Price ($) , 2018-2033 37

5.6 Implantable Ports Market, Canada, Distribution Share by Revenue ($m), 2023 38

5.7 Implantable Ports Market, Canada, Company Share by Revenue ($m), 2023 39

6 Infusion Systems Market, Canada 41

6.1 Infusion Systems Market, Canada, Revenue Mix ($m), 2023 41

6.2 Infusion Systems Market, Canada, Segment Contribution (%), 2023 42

6.3 Infusion Systems Market, Canada, Revenue ($m), 2018-2033 43

6.3.1 Infusion Pump Disposables Market, Canada, Revenue ($m), by Segment, 2018-2033 45

6.3.2 Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033 47

6.4 Infusion Systems Market, Canada, Volume (Units), 2018-2033 49

6.4.1 Infusion Pump Disposables Market, Canada, Volume (Units), by Segment, 2018-2033 51

6.4.2 Infusion Pumps Market, Canada, Volume (Units), by Segment, 2018-2033 53

6.5 Infusion Systems Market, Canada, Average Price ($) , 2018-2033 55

6.6 Infusion Systems Market, Canada, Distribution Share by Revenue ($m), 2023 56

6.7 Infusion Systems Market, Canada, Company Share by Revenue ($m), 2023 57

7 Overview of Key Companies in Canada, Drug Delivery Devices Market 58

7.1 Becton Dickinson and Co 58

7.1.1 Company Overview 58

7.2 B. Braun Melsungen AG 58

7.2.1 Company Overview 58

7.3 Teleflex Inc 58

7.3.1 Company Overview 58

7.4 ICU Medical Inc 58

7.4.1 Company Overview 58

7.5 Edwards Lifesciences Corp 59

7.5.1 Company Overview 59

7.6 Baxter International Inc 59

7.6.1 Company Overview 59

8 Delivery Devices Market Pipeline Products 60

9 Financial Deals Landscape 68

9.1 Acquisition 68

9.1.1 Atai Life Sciences Acquires IntelGenx Technologies and IntelGenx (IGX Entities) 68

9.2 Debt Offerings 69

9.2.1 NuGen Medical Devices Raises USD7.33 Million in Private Placement of 12% Secured Convertible Debentures 69

9.3 Equity Offerings 70

9.3.1 Stockport Exploration (Sona Nanotech) Raises USD1.21 Million in Non-Brokered Private Placement of Shares 70

9.3.2 Cypher Metaverse Raises Funds through Final Tranche Non-Brokered Private Placement of Shares 72

9.3.3 Sona Nanotech Raises USD1.08 Million in Private Placement of Shares 73

9.3.4 Jolt Health to Raise Upto USD0.36 Million in Non-Brokered Private Placement of Units 75

9.3.5 Orion Biotechnology Canada Raises USD0.74 Million in Equity Financing 76

9.3.6 InMed Pharma to Raise Up to USD1.03 Million in Equity Financing 77

10 Recent Developments 78

10.1 Corporate Communications 78

10.1.1 Jan 08, 2025: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies 78

10.1.2 Dec 11, 2024: Netramark Expands Team with the Addition of Industry Veteran 78

10.1.3 Oct 16, 2024: Lobe Sciences Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin 79

10.1.4 Aug 06, 2024: Valeo Pharma Announces Leadership Changes 79

10.1.5 Jun 18, 2024: Cannabix Technologies Announces Annual General and Special Meeting Results 79

10.2 Financial Announcements 80

10.2.1 Feb 10, 2025: Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights 80

10.2.2 Nov 14, 2024: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information 82

10.2.3 Sep 09, 2024: Valeo Pharma to Host Third Quarter 2024 Results Conference Call / Webcast 82

10.2.4 Aug 09, 2024: Elite Pharmaceuticals to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024 82

10.2.5 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 82

10.2.6 Jun 26, 2024: Elite Pharmaceuticals to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024 83

10.2.7 Jun 04, 2024: Valeo Pharma to Host Second Quarter 2024 Results Conference Call / Webcast 83

10.3 Government and Public Interest 83

10.3.1 Sep 04, 2024: Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 83

10.3.2 Apr 25, 2024: Cybin to Participate at the 27th Annual Milken Institute Global Conference 84

10.4 Other Significant Developments 84

10.4.1 Aug 20, 2024: Netramark Provides Q3 Business Update and Highlights Progress 84

10.4.2 Jun 25, 2024: Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant 85

10.4.3 May 17, 2024: Intelgenx Initiates Restructuring Proceedings Under The CCAA To Implement A Review Of Its Strategic Alternatives 86

10.5 Product News 86

10.5.1 Apr 15, 2025: Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom 86

10.5.2 Apr 07, 2025: Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies 87

10.5.3 Jan 31, 2025: This New Drug Delivery Method Could Offer Long-Lasting Relief for Eye Diseases 88

10.5.4 Dec 05, 2024: Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania 88

10.5.5 Dec 02, 2024: BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide 89

10.5.6 Jul 29, 2024: Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA 90

10.6 Research And Development 90

10.6.1 Feb 12, 2025: New Drug Delivery Method Promises Long-Lasting Glaucoma Relief: Study 90

10.7 Strategy And Business Planning 91

10.7.1 Mar 19, 2025: Clearmind Medicine Signs Non-binding Letter of Intent With Polyrizon 91

10.7.2 Sep 24, 2024: Cannabix Technologies and Omega Laboratories Advance Marijuana Breathalyzer Technology – Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference 92

10.7.3 Sep 05, 2024: Positive Results of SB623 for Traumatic Brain Injury, Including Sustained Motor Function Improvement up to 48 weeks, published in Neurology 92

10.7.4 Jun 10, 2024: Netramark Announces Collaboration Agreement with NIMH to Analyze Clinical Trial Data on the Use of Ketamine in Psychiatric Disorders 93

11 Appendix 94

11.1 Research Methodology 95

11.1.1 Coverage 95

11.1.2 Secondary Research 95

11.1.3 Primary Research 96

11.1.4 Market Modeling and Forecasting 97

11.1.5 Company Share Analysis 98

11.1.6 Distribution Share Analysis 98

11.1.7 Benchmarking 99

11.2 GlobalData Consulting 99

11.3 Contact Us 99

11.4 Disclaimer 100

Table

Table 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2023 13

Table 3: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 15

Table 4: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 16

Table 5: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 18

Table 6: Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2023 20

Table 7: Central Venous Catheters Market, Canada, Segment Contribution (%), 2023 22

Table 8: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033 24

Table 9: Central Venous Catheters Market, Canada, Volume (Units), 2018-2033 26

Table 10: Central Venous Catheters Market, Canada, Average Price ($), 2018-2033 27

Table 11: Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023 28

Table 12: Central Venous Catheters Market, Canada, Company Share by Revenue ($m), USD Constant, 2023 30

Table 13: Implantable Ports Market, Canada, Segment Contribution (%), 2023 32

Table 14: Implantable Ports Market, Canada, Revenue ($m), USD Constant, 2018-2033 34

Table 15: Implantable Ports Market, Canada, Volume (Units), 2018-2033 36

Table 16: Implantable Ports Market, Canada, Average Price ($), 2018-2033 37

Table 17: Implantable Ports Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023 38

Table 18: Implantable Ports Market, Canada, Company Share by Revenue ($m), USD Constant, 2023 40

Table 19: Infusion Systems Market, Canada, Segment Contribution (%), 2023 42

Table 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 44

Table 21: Infusion Pump Disposables Market, Canada, Revenue ($m), USD Constant, 2018-2033 46

Table 22: Infusion Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033 48

Table 23: Infusion Systems Market, Canada, Volume (Units), 2018-2033 50

Table 24: Infusion Pump Disposables Market, Canada, Volume (Units), 2018-2033 52

Table 25: Infusion Pumps Market, Canada, Volume (Units), 2018-2033 54

Table 26: Infusion Systems Market, Canada, Average Price ($), 2018-2033 55

Table 27: Infusion Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023 56

Table 28: Infusion Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2023 57

Table 29: Drug Delivery Devices Market Pipeline Products 60

Table 30: Atai Life Sciences Acquires IntelGenx Technologies and IntelGenx (IGX Entities) 68

Table 31: NuGen Medical Devices Raises USD7.33 Million in Private Placement of 12% Secured Convertible Debentures 69

Table 32: Stockport Exploration (Sona Nanotech) Raises USD1.21 Million in Non-Brokered Private Placement of Shares 70

Table 33: Cypher Metaverse Raises Funds through Final Tranche Non-Brokered Private Placement of Shares 72

Table 34: Sona Nanotech Raises USD1.08 Million in Private Placement of Shares 73

Table 35: Jolt Health to Raise Upto USD0.36 Million in Non-Brokered Private Placement of Units 75

Table 36: Orion Biotechnology Canada Raises USD0.74 Million in Equity Financing 76

Table 37: InMed Pharma to Raise Up to USD1.03 Million in Equity Financing 77

Table 38: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country 96

Figures

Figure 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2023 12

Figure 3: Drug Delivery Devices Market, Canada, Category Contribution (%), 2023 13

Figure 4: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 14

Figure 5: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 16

Figure 6: Drug Delivery Devices Market, Canada, Volume (Units), 2018-2033 17

Figure 7: Drug Delivery Devices Market, Canada, Company Share (%) 2023 19

Figure 8: Central Venous Catheters Market, Canada, Revenue Mix ($m), 2023 21

Figure 9: Central Venous Catheters Market, Canada, Segment Contribution (%), 2023 22

Figure 10: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Figure 11: Central Venous Catheters Market, Canada, Volume (Units), 2018-2033 25

Figure 12: Central Venous Catheters Market, Canada, Company Share (%) 2023 29

Figure 13: Implantable Ports Market, Canada, Revenue Mix ($m), 2023 31

Figure 14: Implantable Ports Market, Canada, Segment Contribution (%), 2023 32

Figure 15: Implantable Ports Market, Canada, Revenue ($m), USD Constant, 2018-2033 33

Figure 16: Implantable Ports Market, Canada, Volume (Units), 2018-2033 35

Figure 17: Implantable Ports Market, Canada, Company Share (%) 2023 39

Figure 18: Infusion Systems Market, Canada, Revenue Mix ($m), 2023 41

Figure 19: Infusion Systems Market, Canada, Segment Contribution (%), 2023 42

Figure 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, 2018-2033 43

Figure 21: Infusion Pump Disposables Market, Canada, Revenue ($m), USD Constant, 2018-2033 45

Figure 22: Infusion Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033 47

Figure 23: Infusion Systems Market, Canada, Volume (Units), 2018-2033 49

Figure 24: Infusion Pump Disposables Market, Canada, Volume (Units), 2018-2033 51

Figure 25: Infusion Pumps Market, Canada, Volume (Units), 2018-2033 53

Figure 26: Infusion Systems Market, Canada, Company Share (%) 2023 57

Canada Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Canada Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems in real time.

Access a live Canada Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Canada Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports